GB202002054D0 - Crystalline forms of entrectinib - Google Patents
Crystalline forms of entrectinibInfo
- Publication number
- GB202002054D0 GB202002054D0 GBGB2002054.1A GB202002054A GB202002054D0 GB 202002054 D0 GB202002054 D0 GB 202002054D0 GB 202002054 A GB202002054 A GB 202002054A GB 202002054 D0 GB202002054 D0 GB 202002054D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- entrectinib
- crystalline forms
- crystalline
- forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2002054.1A GB202002054D0 (en) | 2020-02-14 | 2020-02-14 | Crystalline forms of entrectinib |
| US17/755,414 US20220372024A1 (en) | 2019-11-01 | 2020-10-30 | Crystalline forms of entrectinib |
| PCT/GB2020/052740 WO2021084260A1 (en) | 2019-11-01 | 2020-10-30 | Crystalline entrectinib anhydrate and monohydrate forms; crystalline entrectinib thf, nitromethane, isopropyl acetate and methanol solvate forms; processes for preparing a crystalline entrectinib anhydrate form |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2002054.1A GB202002054D0 (en) | 2020-02-14 | 2020-02-14 | Crystalline forms of entrectinib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202002054D0 true GB202002054D0 (en) | 2020-04-01 |
Family
ID=69956630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2002054.1A Ceased GB202002054D0 (en) | 2019-11-01 | 2020-02-14 | Crystalline forms of entrectinib |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB202002054D0 (en) |
-
2020
- 2020-02-14 GB GBGB2002054.1A patent/GB202002054D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3619208C0 (en) | Crystalline forms of a jak inhibitor compound | |
| EP4121045A4 (en) | Crystalline norpsilocin compounds | |
| EP4120820A4 (en) | Crystalline psilacetin derivatives | |
| IL282552A (en) | Crystalline forms of mnk inhibitors | |
| EP3684358A4 (en) | New crystalline polymorph of ponesimod | |
| IL289929A (en) | Crystalline forms of a cd73 inhibitor | |
| PL3532457T3 (en) | Crystalline forms of hydroxynorketamine | |
| EP3897660A4 (en) | Novel crystalline forms of an nrtti compound | |
| SI3749673T1 (en) | Crystalline form of bictegravir sodium | |
| IL285219A (en) | Crystal of diarylthiohydantoin compound | |
| EP3793980A4 (en) | Crystalline form of s-apomorphine | |
| IL270961A (en) | Crystalline form of n-butyldeoxygalactonojirimycin | |
| IL269073A (en) | Crystalline forms of obeticholic acid | |
| EP4139297A4 (en) | Crystalline forms of phthacaz1nonf compound | |
| GB201912411D0 (en) | Crystalline forms of ivosidenib | |
| EP4121434A4 (en) | Crystalline forms of squalamine | |
| IL285493A (en) | Crystalline forms of an rsk inhibitor | |
| SG11202108905UA (en) | Crystalline form of an avibactam derivative | |
| GB202009218D0 (en) | Crystalline forms of entrectinib | |
| GB202002054D0 (en) | Crystalline forms of entrectinib | |
| IL289214A (en) | Crystalline forms of plasma kallikrein inhibitors | |
| GB201915908D0 (en) | Crystalline forms of entrectinib | |
| GB202112804D0 (en) | Crystalline forms | |
| GB202008588D0 (en) | Crystalline forms | |
| EP4093402A4 (en) | Crystalline form c of vortioxetine hydrobromide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |